Please login to the form below

Not currently logged in
Email:
Password:

divestments

This page shows the latest divestments news and features for those working in and with pharma, biotech and healthcare.

Shire rebuffs Takeda bids, as Allergan bows out

Shire rebuffs Takeda bids, as Allergan bows out

that has since been followed by at least 18 other bolt-on buys or divestments to bolster and refine its product portfolio and pipeline.

Latest news

More from news
Approximately 2 fully matching, plus 67 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    Teva/Alder Biopharmaceuticals patent settlement. We have featured Teva in Deal Watch over the last few months but focused more on the company's divestment activities to tackle its debt crisis.

  • Deal Watch February 2017 Deal Watch February 2017

    The largest of these was Perrigo's divestment to Royalty Pharma of its royalty stream from Biogen's global sales of Tysabri (natalizumab), the multiple sclerosis antibody originally developed by Elan, ... Sanofi's $88.3m deal with Ipsen covers the

  • 2016: The year when deal-makers took stock? 2016: The year when deal-makers took stock?

    Out-partnering deals included the $1.1bn licence to LEO for tralokinumab in skin diseases and the $1bn divestment to Pfizer of its late-stage small molecule anti-infective business. ... will contribute to a decline in the number of M&A deals over $5bn,

  • Deal Watch January 2017 Deal Watch January 2017

    1, 600. Valeant. L'Oreal. Divestment. CeraVe AcneFree AMBI. 1, 300. Forward Pharma. ... 960. Valeant. Sanpower Group. Divestment. Dendreon equity interest. 820. Delinia. Celgene.

  • Deal Watch October 2016 Deal Watch October 2016

    They must have been working eight days a week! Core therapy area acquisitions and non-core divestments are changing the shape of AstraZeneca. ... The Month of Divestments – We Can Work It Out. At least AstraZeneca are making a proactive approach to

More from intelligence
Approximately 0 fully matching, plus 29 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Global Corporate Divestment Study

    No longer a sign of weakness or failure, divestment in life sciences continued to heat up last year. ... In fact, 87% of life sciences companies say their most recent divestment created long-term value in their remaining company.

  • Portfolio Optimisation: Can you really compare Apples to Oranges?

    1] EY Life Sciences Global Corporate Divestment Study -2016 .

  • EY Life Sciences

    No longer a sign of weakness or failure, divestment in life sciences continued to heat up last year. ... In fact, 87% of life sciences companies say their most recent divestment created long-term value in their remaining company.

  • Management consultancies

    Company Acquisitions, Divestments and Mergers and Consultancy and Commercial support services.

  • Andrew Waide Associates Ltd

    Distributor service; Brand and Company Acquisitions, Divestments and Mergers and Consultancy and Commercial support services.

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
McCann Health

The most globally awarded health agency network and currently Health Network agency of The Year. Comprising of two specialist agencies:...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics